Video

Educated Patient® MPN Summit: August 28, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient MPN Summit on demand.

Related Videos
Dr. Richard “Rick" Winneker
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with grey hair.
Image of bald man in suit.
Image of woman with dark hair, smiling.
Image of woman with brown hair.
Image of man with grey hair.
Image of woman with black hair.
Related Content
Illustration of red blood cells.
January 20th 2025

Subcutaneous Dacogen Elicits Responses Among Some With Myelofibrosis

Alex Biese
Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Image of woman holding a pink ribbon.
December 31st 2024

Low ctDNA Levels May Show Longer Recurrence-Free Interval in Breast Cancer

Spencer Feldman
In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of a person with a tumor in their left breast.
December 26th 2024

Top 5 Stories from the 2024 San Antonio Breast Cancer Symposium

Darlene Dobkowski, MA
CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer, in addition to treatment strategies.
Illustration of red cell.
December 25th 2024

Monjuvi Combination May Improve Survival in Follicular Lymphoma

Caroline Seymour
Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory follicular lymphoma.